As of May 22
| +0.05 / +1.25%|
The 1 analysts offering 12-month price forecasts for Adamis Pharmaceuticals Corp have a median target of 15.00, with a high estimate of 15.00 and a low estimate of 15.00. The median estimate represents a +270.37% increase from the last price of 4.05.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.